2018 Webinar: Cardiac Risk in Liver Transplantation: Getting to the “Heart” of the Matter

4 (1 vote)

Recorded On: 09/10/2018

Registration Closed

The overall objective of this activity is to address the epidemiology, risk factors and key challenges in the evaluation and management of cardiovascular disease in liver transplant candidates. In particular, we will discuss the evolving role of cirrhotic cardiomyopathy as a marker of ongoing cardiac injury.

Lisa VanWagner (Moderator)

Dr. Lisa VanWagner is an Assistant Professor of Medicine-GI & Hepatology and Preventive Medicine-Epidemiology at Northwestern University in Chicago, IL. Dr. VanWagner utilizes human population-based approaches, large electronic health record data analysis and health services research methods to define and characterize cardiovascular disease (risk prediction, prevention and treatment approaches in patients with chronic liver disease. Notably, she leads the multicenter Advancing Liver Therapeutic Approaches (ALTA) Consortium Study Group for the Management of Portal Hypertension and is the lead Principal investigator for ALTA TIPS, a U.S. based longitudinal observational study of patients who are undergoing transjugular intrahepatic portosystemic shunt (TIPS) placement. ALTA will create a database that will provide clinical parameters and outcomes of patients undergoing TIPS as part of their standard of care in hopes of answering key clinical questions about the utilization, outcomes and best practices surrounding TIPS as a therapeutic intervention for the complications of portal hypertension. She is an active member of AASLD, currently serving as a member of the Practice Guidelines Committee and is an Associate Editor for Liver Transplantation and Clinical Liver Disease.

Sam Lee (Moderator)

Mario Altieri

Dr. Mario Altieri is currently the medical director of the liver transplant program at the University Hospital Center in Caen, France since November, 2012. He did his Fellowship in intensive care medicine and Fellowship in multiple organ transplantation (liver, kidney and pancreas) at Strasbourg University France Hospital, University Center Hospital HUC. He was the Chief of residency in Internal Medicine Cordoba, Argentina (Specialist certified NUCA) and was professor in intensive care medicine catholic University of Cordoba from 2000 to 2002.

Manhal Izzy

Dr. Manhal Izzy is a transplant hepatologist and an assistant professor at Vanderbilt University School of Medicine. He is a member of the educational committee of the International Liver Transplantation Society (ILTS). His research focuses on cardiovascular outcomes in patients with liver disease.